[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,513,985
  • Shares Outstanding, K 82,949
  • Annual Sales, $ 1,731 M
  • Annual Income, $ 682,640 K
  • EBIT $ -25 M
  • EBITDA $ -3 M
  • 60-Month Beta 0.56
  • Price/Sales 3.51
  • Price/Cash Flow 8.35
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 46.69% (+0.44%)
  • Historical Volatility 59.40%
  • IV Percentile 21%
  • IV Rank 24.88%
  • IV High 77.63% on 04/24/26
  • IV Low 36.45% on 01/21/26
  • Expected Move (DTE 29) 3.16 (3.99%)
  • Put/Call Vol Ratio 0.48
  • Today's Volume 924
  • Volume Avg (30-Day) 165
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 12,926
  • Open Int (30-Day) 12,219
  • Expected Range 75.99 to 82.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.11
  • Number of Estimates 4
  • High Estimate $0.52
  • Low Estimate $-0.24
  • Prior Year $-0.83
  • Growth Rate Est. (year over year) +113.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.17 +17.28%
on 05/26/26
80.00 -1.54%
on 06/18/26
+8.62 (+12.29%)
since 05/18/26
3-Month
63.18 +24.68%
on 05/01/26
80.00 -1.54%
on 06/18/26
+11.77 (+17.57%)
since 03/18/26
52-Week
43.17 +82.44%
on 08/11/25
87.50 -9.98%
on 11/26/25
+28.34 (+56.20%)
since 06/18/25

Most Recent Stories

More News
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J. , June 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 11, 2026, the company approved non-statutory stock options to purchase an aggregate...

PTCT : 78.75 (+0.28%)
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes

– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible notes prior to or at maturity –

PTCT : 78.75 (+0.28%)
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes

– Proceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity –

PTCT : 78.75 (+0.28%)
PTC Therapeutics Q1 Earnings Call Highlights

PTC Therapeutics (NASDAQ:PTCT) reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or PKU.Chief...

PTCT : 78.75 (+0.28%)
PTC Therapeutics: Q1 Earnings Snapshot

PTC Therapeutics: Q1 Earnings Snapshot

PTCT : 78.75 (+0.28%)
PTC Therapeutics Reports With Votoplam Data Already Digested and Guidance Still Unclear

Barchart Research What to Expect from PTCT Earnings PTCT Generated May 6, 2026 Current Price $66.57 EPS Estimate $$-0.31 Consensus Rating Moderate Buy Average Move 7.20% PTC Therapeutics Reports With Votoplam...

PTCT : 78.75 (+0.28%)
PTC Therapeutics to Participate in Upcoming Investor Conferences

WARREN, N.J. , May 4, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:

PTCT : 78.75 (+0.28%)
PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam

- Dose-dependent benefit on cUHDRS in Stage 2 participants compared to matched natural history cohort, with 52% slowing at 10 mg dose -

PTCT : 78.75 (+0.28%)
PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study

WARREN, N.J. , April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call today, April 28 at 4:30 p.m. ET to share results from the 24-month interim...

PTCT : 78.75 (+0.28%)
PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

WARREN, N.J. , April 22, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its first quarter 2026 financial...

PTCT : 78.75 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

See More

Key Turning Points

3rd Resistance Point 85.20
2nd Resistance Point 82.40
1st Resistance Point 80.46
Last Price 78.75
1st Support Level 75.73
2nd Support Level 72.93
3rd Support Level 70.99

See More

52-Week High 87.50
Last Price 78.75
Fibonacci 61.8% 70.57
Fibonacci 50% 65.34
Fibonacci 38.2% 60.11
52-Week Low 43.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.